Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit E Cudkowicz

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Case Reports in Medicine|October 15, 2009
Profound muscle weakness and pain after one dose of actonelIrina Badayan, Merit E Cudkowicz
Neurology|March 24, 2010
CSF markers in amyotrophic lateral sclerosis: has the time come?Merit E Cudkowicz, Michael Swash
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|September 27, 2008
Is it too soon for mesenchymal stem cell trials in people with ALS?Irina Badayan, Merit E Cudkowicz
The New England Journal of Medicine|December 2, 2020
Sodium Phenylbutyrate-Taurursodiol for ALS. ReplySabrina Paganoni, Merit E Cudkowicz
Annals of Neurology|April 28, 2022
Regulatory Approval in ALS; When Is a Single Study Enough?Merit E Cudkowicz, Jeremy M Shefner
Frontiers of Neurology and Neuroscience|May 30, 2009
Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and complianceRichard S Bedlack, Merit E Cudkowicz
Journal of Clinical Pharmacology|November 18, 2005
Clinical trials in amyotrophic lateral sclerosis: the tenuous past and the promising futureRabia B Choudry, Merit E Cudkowicz
Annals of Neurology|June 18, 2024
Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about Amyotrophic Lateral Sclerosis Clinical ResearchJeremy M Shefner, Merit E Cudkowicz
Neurology|May 3, 2014
Locked in, but not out?Leigh R Hochberg, Merit E Cudkowicz
Biochimica Et Biophysica Acta|May 23, 2006
Translating preclinical insights into effective human trials in ALSAllitia B DiBernardo, Merit E Cudkowicz
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Case Reports in Medicine|October 15, 2009
Profound muscle weakness and pain after one dose of actonelIrina Badayan, Merit E Cudkowicz
Neurology|March 24, 2010
CSF markers in amyotrophic lateral sclerosis: has the time come?Merit E Cudkowicz, Michael Swash
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|September 27, 2008
Is it too soon for mesenchymal stem cell trials in people with ALS?Irina Badayan, Merit E Cudkowicz
The New England Journal of Medicine|December 2, 2020
Sodium Phenylbutyrate-Taurursodiol for ALS. ReplySabrina Paganoni, Merit E Cudkowicz
Annals of Neurology|April 28, 2022
Regulatory Approval in ALS; When Is a Single Study Enough?Merit E Cudkowicz, Jeremy M Shefner
Frontiers of Neurology and Neuroscience|May 30, 2009
Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and complianceRichard S Bedlack, Merit E Cudkowicz
Journal of Clinical Pharmacology|November 18, 2005
Clinical trials in amyotrophic lateral sclerosis: the tenuous past and the promising futureRabia B Choudry, Merit E Cudkowicz
Annals of Neurology|June 18, 2024
Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about Amyotrophic Lateral Sclerosis Clinical ResearchJeremy M Shefner, Merit E Cudkowicz
Neurology|May 3, 2014
Locked in, but not out?Leigh R Hochberg, Merit E Cudkowicz
Biochimica Et Biophysica Acta|May 23, 2006
Translating preclinical insights into effective human trials in ALSAllitia B DiBernardo, Merit E Cudkowicz
Pageof 16